NovoCure Ltd (NVCR)
13.93
+1.19
(+9.34%)
USD |
NASDAQ |
May 02, 15:26
NovoCure Price to Book Value: 4.135 for May 2, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 01, 2024 | 3.782 |
| April 30, 2024 | 3.633 |
| April 29, 2024 | 3.800 |
| April 26, 2024 | 3.751 |
| April 25, 2024 | 3.630 |
| April 24, 2024 | 3.663 |
| April 23, 2024 | 3.578 |
| April 22, 2024 | 3.512 |
| April 19, 2024 | 3.589 |
| April 18, 2024 | 3.577 |
| April 17, 2024 | 3.577 |
| April 16, 2024 | 3.699 |
| April 15, 2024 | 3.776 |
| April 12, 2024 | 4.028 |
| April 11, 2024 | 4.192 |
| April 10, 2024 | 4.340 |
| April 09, 2024 | 4.417 |
| April 08, 2024 | 4.209 |
| April 05, 2024 | 4.079 |
| April 04, 2024 | 4.242 |
| April 03, 2024 | 4.281 |
| April 02, 2024 | 4.272 |
| April 01, 2024 | 4.576 |
| March 28, 2024 | 4.618 |
| March 27, 2024 | 4.325 |
| Date | Value |
|---|---|
| March 26, 2024 | 3.861 |
| March 25, 2024 | 3.900 |
| March 22, 2024 | 3.903 |
| March 21, 2024 | 4.121 |
| March 20, 2024 | 4.027 |
| March 19, 2024 | 4.000 |
| March 18, 2024 | 4.083 |
| March 15, 2024 | 4.130 |
| March 14, 2024 | 4.316 |
| March 13, 2024 | 4.378 |
| March 12, 2024 | 4.517 |
| March 11, 2024 | 4.724 |
| March 08, 2024 | 4.886 |
| March 07, 2024 | 5.108 |
| March 06, 2024 | 4.919 |
| March 05, 2024 | 4.816 |
| March 04, 2024 | 4.854 |
| March 01, 2024 | 4.801 |
| February 29, 2024 | 4.523 |
| February 28, 2024 | 4.733 |
| February 27, 2024 | 4.816 |
| February 26, 2024 | 4.402 |
| February 23, 2024 | 4.496 |
| February 22, 2024 | 4.502 |
| February 21, 2024 | 4.615 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
3.021
Minimum
Nov 10 2023
62.69
Maximum
Jun 23 2021
26.70
Average
24.85
Median
Price to Book Value Benchmarks
| AtriCure Inc | 2.295 |
| NeuroMetrix Inc | 0.4251 |
| Repligen Corp | 4.660 |
| Teleflex Inc | 2.118 |
| Perspective Therapeutics Inc | 13.66 |
Price to Book Value Related Metrics
| PS Ratio | 2.910 |
| PEG Ratio | -0.0587 |
| Price | 13.93 |
| Earnings Yield | -14.00% |
| Market Cap | 1.499B |
| PEGY Ratio | -0.0587 |